DTIL

Bullish

Precision BioSciences stock (US74019P1084): Is its gene editing platform strong enough to unlock biotech upside?

This report analyzes Precision BioSciences (US74019P1084) and its proprietary ABLYS gene editing platform, assessing its potential to deliver breakthr...

AD HOC NEWS Yesterday 0

Bullish

Precision BioSciences reports encouraging muscle improvements in preclinical DMD gene therapy study

Precision BioSciences announced positive preclinical results for its Duchenne muscular dystrophy (DMD) gene editing program. The study, conducted in a...

MSN 6 days ago 0